Target intelligence / Profile preview

Tear film and ocular surface cell

Molecular classification
Other
01

Overview

The **tear film** is a thin, complex, multi-layered fluid coating the ocular surface, composed of a lipid layer (from meibomian glands), an aqueous-mucin layer (from lacrimal glands and goblet cells), and a glycocalyx (from surface epithelial cells)[1][3][4]. The tear film protects and lubricates the eye, supports clear vision, defends against infection, promotes healing after injury, and maintains comfort by preventing desiccation and reducing mechanical friction[1][2]. **Ocular surface cells** refers primarily to the epithelial cells of the cornea and conjunctiva, which both contribute structurally and by expressing specific membrane-bound mucins[4]. Dysfunction or alteration of the tear film or ocular surface cells, individually or collectively, leads to clinical conditions such as dry eye disease, increased risk of infection, ocular pain, and fluctuations in vision[1][2][3]. There is no single molecular "target" within this system; rather, multiple proteins (e.g., mucins, antimicrobial peptides, growth factors) and processes are involved in tear film stability, production, and ocular health maintenance[1][2][3][4]. **Summary:** "Tear film and ocular surface cells" is an anatomical and functional entity, not a molecular target. It encompasses multiple cell types and secretions, with varied biological functions, and is not suited as an entry for a single druggable target or receptor.

Other names
Tear filmocular surfaceocular surface epitheliumlacrimal functional unit
02

Biological functions

Protection of the ocular surfaceLubrication of the eyeMaintenance of smooth optical surface for visionWound healingImmune defenseSuppression of inflammation
03

Disease associations

Dry eye disease (dysfunction or deficiency)Ocular surface diseaseInflammationNeuropathic pain (in context of corneal nerves)

Beyond the preview

Go deeper on Tear film and ocular surface cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tear film and ocular surface cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call